Connect with us

Hi, what are you looking for?

Jewish Business News


Irish Healthcare Covidien Acquires Israeli Given Imaging For $860 Million

Given Imaging CEO: After thoroughly evaluating our options we determined that this deal is in the best interests of Given Imaging.
pillcam Given Imaging
Irish healthcare company Covidien plc (NYSE: COV) has acquired IDB Holding Corp. Ltd. (TASE:IDBH) unit capsule endoscope developer Given Imaging Ltd.(Nasdaq: GIVN; TASE: GIVN) for $860 million, net of cash and investments acquired.

Covidien is paying $30 per share, a 15% premium on the share’s closing price on Nasdaq on Friday night when the company had a market cap of $753 million. IDB subsidiary Discount Investment Corporation (TASE: DISI) owns 14.7% of Given Imaging, subsidiary Elron Electronic Industries Ltd. (TASE: ELRN), owns 21.2%, including 8.3% through RDC, its joint venture with Rafael Advanced Defense Systems Ltd. in equal shares. Discount Investment said that it would make $142 million on the sale, Elron said that it would make $204 million, and RDC will make $80 million.

Covidien said, “This transaction provides Covidien additional scale and scope to serve the multibillion dollar global gastrointestinal (GI) market and supports the company’s strategy to comprehensively address key global specialties and procedures. We believe Given Imaging is one of the most attractive specialty procedure areas. Acquiring Given will enable Covidien to significantly expand its presence in a $3 billion GI market”

Please help us out :
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at
Thank you.

Covidien added, “Given Imaging provides one of the broadest technology platforms for visualizing, diagnosing and monitoring the digestive system, including its flagship PillCam, an innovative swallowed capsule endoscope.

Covidien group president medical devices & US said, “Adding Given’s portfolio of diagnostics to our portfolio accelerates Covidien’s strategy of providing physicians with products that support the patient along the care continuum from diagnosis to treatment. It also confirms our leadership in developing less-invasive screening, diagnosis and treatment solutions that can improve patient outcomes and lower healthcare costs.”

Given Imaging president and CEO Homi Shamir said, “Given Imaging revolutionized GI diagnostics over 12 years ago with the launch of PillCam and created an entirely new diagnostic category – capsule endoscopy. The combination of Covidien’s established global presence and Given Imaging’s innovative capabilities has the potential to transform this market. After thoroughly evaluating our strategic options we determined that this transaction is in the best interests of Given Imaging, its shareholders and employees and provides unique benefits to patients globally.”

Covidien has previously acquired three Israeli medical device companies, all of them in 2012 – respiratory monitor developer Oridion for $346 million, bronchial tubes endoscope maker SuperDimension for $300 million, and hernia mesh company PolyTouch for $40 million.

Published by 



You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...


The Movie The Professional is what made Natalie Portman a Lolita.


After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

VC, Investments

You may not become a millionaire, but there is a lot to learn from George Soros.

Copyright © 2021 Jewish Business News